Co-Chair
Stefan D. Anker, MD, PhD (Activity Chair)
Professor of Cardiology and Cachexia Research,
Department of Cardiology
Charite University
Berlin, Germany
Faculty Listing
Katherine E. Di Palo, PharmD, FAHA, FHFSA, BCACP, BCGP
Clinical Program Manager
Hospital Readmissions Reduction Program
Montefiore Medical Center
Assistant Professor of Medicine
Albert Einstein College of Medicine
Bronx, NY
Muthiah Vaduganathan, MD, MPH
Instructor in Medicine
Harvard Medical School
Brigham and Women’s Hospital
Cardiovascular Medicine
Boston, MA
Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
The Mary and Gordon Cain Chair and Professor of Medicine
Associate Provost of Faculty Affairs
Senior Associate Dean of Faculty Development
Director, Winters Center for Heart Failure Research
Assoc. Director, Cardiovascular Research Institute
Vice-Chair of Medicine, Baylor College of Medicine
Medicine Chief, DeBakey VA Medical Center
Houston, TX
Faculty Disclosures
In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grant, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Planners
Stefan D. Anker, MD, PhD - has disclosed that he is a consultant for Bayer, BI, Novartis, Occlutech, Cardiac Dimension, and Servier and receives grant/research support from Abbott and Vifor.
Bryan Taylor, PharmD - has no relevant financial relationships to disclose in relation to the content of this activity.
Authors/Presenters
Stefan D. Anker, MD, PhD - has disclosed that he is a consultant for Bayer, BI, Novartis, Occlutech, Cardiac Dimension, and Servier and receives grant/research support from Abbott and Vifor.
Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP - has disclosed that she is a consultant for Bayer, scPharmaceuticals, Relypsa, and Vifor.
Katherine E. Di Palo, PharmD, FAHA, FHFSA, BCACP, BCGP - has no relevant financial relationships to disclose in relation to the content of this activity.
Muthiah Vaduganathan, MD, MPH - has disclosed that he is a consultant for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, and Relypsa and has received research grant support or served on advisory boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Cytokinetics, and Relypsa and has participated in speaker engagements with Novartis.
Peer Reviewer
Larry Allen, MD, MHS, FHFSA - has disclosed that he is a consultant for Amgen, Boston Scientific, Cytokinetics, and Novartis.